Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy
Authors:
- Hiroaki InoueHIHiroaki Inoue
- Shinya RaiSRShinya Rai
- Hirokazu TanakaHTHirokazu Tanaka
- J. Luis EspinozaJ. Luis Espinoza
- Maiko Komori-InoueMKMaiko Komori-Inoue
- Hiroaki KakutaniHKHiroaki Kakutani
- Shuji MinamotoSMShuji Minamoto
- Takahiro KumodeTKTakahiro Kumode
- Shoko NakayamaSNShoko Nakayama
- Yasuhiro TaniguchiYTYasuhiro Taniguchi
- Yasuyoshi MoritaYMYasuyoshi Morita
- Takeshi OkudaTOTakeshi Okuda
Open Access
Abstract
Aplastic anemia is a rare blood disease characterized by the destruction of the hematopoietic stem cells (HSC) in the bone marrow that, in the majority of cases, is caused by an autoimmune reaction. Patients with aplastic anemia are treated with immunosuppressive drugs and some of them, especially younger individuals with a donor available, can be successfully treated with hematopoietic stem cell transplantation (HSCT). We report here a rare case of post-transplant lymphoproliferative disorder (PTLD) associated with Epstein–Barr virus (EBV) reactivation in a 30-year-old female patient who underwent allogeneic HSCT for severe aplastic anemia. The PTLD, which was diagnosed 230 days after transplantation, was localized exclusively in the central nervous system (specifically in the choroid plexus) and manifested with obvious signs of intracranial hypertension. After receiving three cycles of high dose methotrexate (HD-MTX) combined with rituximab, the patient achieved a complete clinical recovery with normalization of blood cell counts, no evidence of EBV reactivation, and no associated neurotoxicity.Keywords
This publication has 36 references indexed in Scilit:
- Choroid plexus tumor epidemiology and outcomes: implications for surgical and radiotherapeutic managementJournal of Neuro-Oncology, 2014
- Lesões expansivas intraventriculares à ressonância magnética: ensaio iconográfico - parte 1Radiologia Brasileira, 2014
- Rituximab monotherapy for patients with recurrent primary CNS lymphomaNeurology, 2011
- High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trialThe Lancet Oncology, 2010
- High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trialThe Lancet, 2009
- Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disordersMultiple Sclerosis Journal, 2008
- Primary high-grade B-cell lymphoma of the choroid plexusClinical Neurology and Neurosurgery, 2008
- Epstein–Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical courseAnnals of Hematology, 2006
- Primary choroid plexus T-cell lymphoma and multiple aneurysms in the CNSLeukemia & Lymphoma, 2006
- Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the lateral ventricleLeukemia & Lymphoma, 2005